Epigenetic markers as promising prognosticators for bladder cancer. - Wikidata - wikimedia - TriplyDB

Epigenetic markers as promising prognosticators for bladder cancer.

Epigenetic markers as promising prognosticators for bladder cancer.

http://www.wikidata.org/entity/Q37249752

about

Potential new urinary markers in the early detection of bladder cancer.Identification of methylated genes associated with aggressive bladder cancer.Long-term use of valproic acid in US veterans is associated with a reduced risk of smoking-related cases of head and neck cancer.DNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach.Biomarkers for prognosis and treatment selection in advanced bladder cancer patients.Clinical significance of CDH13 promoter methylation as a biomarker for bladder cancer: a meta-analysis FAM70B as a Novel Prognostic Marker for Cancer Progression and Cancer-Specific Death in Muscle-Invasive Bladder Cancer.DNA methylation as a universal biomarker.Methods for the discovery of low-abundance biomarkers for urinary bladder cancer in biological fluids.Immunohistochemical biomarkers for bladder cancer prognosis.DNA methylation profiles in precancerous tissue and cancers: carcinogenetic risk estimation and prognostication based on DNA methylation status.Hypermethylation in bladder cancer: biological pathways and translational applications.Biomolecular predictors of urothelial cancer behavior and treatment outcomes.Republished: non-invasive urine based tests for the detection of bladder cancer.Increased SPHK1 expression is associated with poor prognosis in bladder cancer.Novel combination markers for predicting progression of nonmuscle invasive bladder cancer.Diagnostic and prognostic role of urinary collagens in primary human bladder cancer.DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects.Bladder cancer: Micro RNAs as biomolecules for prognostication and surveillance.Aberrant Methylation of MEG3 Functions as a Potential Plasma-Based Biomarker for Cervical Cancer.Aberrant methylation of CDH11 predicts a poor outcome for patients with bladder cancer.Clinical significance of CDH13 promoter methylation in serum samples from patients with bladder transitional cell carcinoma.Detection of hyaluronidase RNA and activity in urine of schistosomal and non-schistosomal bladder cancer.A methylation assay for the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences in voided urine.Promoter methylation of H-cadherin is a potential biomarker in patients with bladder transitional cell carcinoma.Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring

P2860

Q33657098-96602E2C-3B34-4799-A05A-1C7269B1A5FB Q33680247-60B46F6C-4B11-43B9-A140-2882EB88D852 Q33915416-FD4C823F-B13D-4468-BB20-ED6887B2F5E4 Q34249360-DF2FA424-6736-4095-A06F-CDCD59EBD28E Q35671292-FA0386B6-21F1-4001-A08C-19ECB6C82D16 Q36117964-B2FD1CF5-1AA1-4501-A2AF-E8DD4B7992BA Q36284742-A039EBA2-6E1C-4FF8-8FBD-6F52425B5F45 Q37750858-85974AD6-3F21-460D-A856-B26683667BED Q37810251-1E269D44-E254-442D-992F-08075202C96A Q37902697-0DE1BCB2-F83B-459B-9AF1-DF52457FD00B Q37961740-D4BE8683-9CE2-4EAF-83E2-F4A6E418DAE6 Q37978544-70D3BF6A-6479-4373-98FB-A26557A45ECD Q37987066-A0D66584-31DF-47A2-B1C6-CD7D32FFEE1C Q38107899-7BFBC3F0-AFFD-42E4-AFDD-D605B661197A Q38394714-59700DAD-EA47-443B-851B-3E96087D9B83 Q38469299-B8F59E71-FCA8-4251-8F4B-1E8B8FF17F54 Q38610283-4835B41C-7A36-48F9-BA12-6D1AF9D58385 Q38833395-D298A82F-4BD6-4BA5-A9B8-5B3F8C650F13 Q39281568-D76688C2-7698-4CFE-98AF-8583BCDE86A8 Q40121556-2F2A2F43-1312-4AB3-94E0-8481C39D6BA9 Q42364210-0707D5C8-67B4-4D17-A52D-DD614227733A Q44045391-1FCDEB13-3419-4B07-A4BC-420BFA3EA994 Q44204551-DDF170D6-FB3B-461E-A116-DB9E7AEE17C5 Q54357139-CF328747-ADF7-4FCA-9AA0-06FA9B33CDDE Q54376271-2B617644-613C-40C2-93B7-503FE0152A18 Q58704141-499C5539-31F3-42E5-BAA0-96ABACAF8276

P2860

Epigenetic markers as promising prognosticators for bladder cancer.

http://www.wikidata.org/entity/Q37249752

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 August 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Epigenetic markers as promising prognosticators for bladder cancer.

@en

Epigenetic markers as promising prognosticators for bladder cancer.

@nl

type

label

Epigenetic markers as promising prognosticators for bladder cancer.

@en

Epigenetic markers as promising prognosticators for bladder cancer.

@nl

prefLabel

Epigenetic markers as promising prognosticators for bladder cancer.

@en

Epigenetic markers as promising prognosticators for bladder cancer.

@nl

P1433

Q37249752-24130898-E1B6-490E-BD46-1E3DA99A0589

P1476

Q37249752-E69AD807-D865-491A-96E5-DC673CE39B14

P2093

Q37249752-7172083B-2EB8-4651-B65F-DF220E80164D

Q37249752-746E25B8-B41D-4637-B802-AA4B224F5BA9

P2860

Q37249752-11407FFE-884A-4200-ADEA-F3B1015868F7

Q37249752-1540EE4B-E372-487A-89A6-35CE39BB3F48

Q37249752-1EDE0807-26F7-4219-A50E-94014910F266

Q37249752-40943333-40EA-41E1-B639-5EAA66E78C7E

Q37249752-42C03E37-9BE1-44C6-B557-C819D9AE5273

Q37249752-493434E1-652D-4AAD-89FB-2B37ACC29F6E

Q37249752-52D27EBC-4589-4B7E-B02A-978352FBA844

Q37249752-546F4599-2DAF-4CBE-A79A-237DEE567827

Q37249752-5707B73D-4EC5-49F1-96CB-BE950E838CDD

Q37249752-5960B110-66F0-4A4A-A216-B098A2C545A8

P304

Q37249752-6F312FD8-400B-42AD-9BE2-72719F5FD212

P31

Q37249752-56ED2060-F0F8-4D22-ABF0-F42E65581412

Q37249752-9357d636-abed-4538-b5c0-99033f9a9e17

P356

Q37249752-83178EA6-D1C9-43C1-874A-A5E80B06B09B

P433

Q37249752-49CAB513-E594-48AD-B166-A14262BA43A2

P478

Q37249752-236A2F26-559F-44F6-8834-1C85CE26B558

P577

Q37249752-668C7BAF-4178-4DFE-AE44-0DEE1910A2DD

P5875

Q37249752-5BD0BD79-3C05-49FD-97CC-5567EE3D701E

P698

Q37249752-C6EE50E7-3929-471D-9A8C-3916FFB48716

P356

J.1442-2042.2008.02143.X

P1433

International Journal of Urology

P1476

Epigenetic markers as promising prognosticators for bladder cancer.

@en

P2093

Wun-Jae Kim

http://www.w3.org/2001/XMLSchema#string

Young Kyoon Kim

http://www.w3.org/2001/XMLSchema#string

P2860

The power and the promise of DNA methylation markers

Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells

Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel

Genetic unmasking of an epigenetically silenced microRNA in human cancer cells

Epigenetics in cancer

Cancer epigenomics: DNA methylomes and histone-modification maps

Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome

Gene silencing in cancer in association with promoter hypermethylation

Cancer epigenetics comes of age

Hypomethylation distinguishes genes of some human cancers from their normal counterparts

P304

17-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1442-2042.2008.02143.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23188159

http://www.w3.org/2001/XMLSchema#string

P698

18721202

http://www.w3.org/2001/XMLSchema#string